Home

oldal sötét véletlenül giorgina specchia curriculum Opera cache dal

CODICE CONCORSO 2019POR023 PROCEDURA VALUTATIVA DI CHIAMATA PER LA  COPERTURA DI N.1 POSTO DI PROFESSORE UNIVERSITARIO DI RUOLO D
CODICE CONCORSO 2019POR023 PROCEDURA VALUTATIVA DI CHIAMATA PER LA COPERTURA DI N.1 POSTO DI PROFESSORE UNIVERSITARIO DI RUOLO D

IJMS | Free Full-Text | TP53 in Myelodysplastic Syndromes: Recent  Biological and Clinical Findings
IJMS | Free Full-Text | TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings

program outcome in follicular lymphomas treated with a rituximab-intensive  Persistence of minimal residual disease in bone marro
program outcome in follicular lymphomas treated with a rituximab-intensive Persistence of minimal residual disease in bone marro

Giorgina SPECCHIA | Research profile
Giorgina SPECCHIA | Research profile

Prof.ssa Giorgina Specchia - Pianeta Salute
Prof.ssa Giorgina Specchia - Pianeta Salute

Untitled
Untitled

Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma -  ScienceDirect
Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma - ScienceDirect

Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic  Malignancies
Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies

Chronic myeloid leukemia (CML) - List of Frontiers' open access articles
Chronic myeloid leukemia (CML) - List of Frontiers' open access articles

Giorgina Specchia: “Farmaci intelligenti. Una rivoluzione in terapia” -  YouTube
Giorgina Specchia: “Farmaci intelligenti. Una rivoluzione in terapia” - YouTube

Ferrata Storti Foundation
Ferrata Storti Foundation

Prof.ssa Giorgina Specchia: ematologa a Bari
Prof.ssa Giorgina Specchia: ematologa a Bari

PDF) The long-term durability of cytogenetic responses in patients with  accelerated phase chronic myeloid leukemia treated with imatinib 600 mg:  the GIMEMA CML Working Party experience after a 7-year follow-up | Luciano
PDF) The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up | Luciano

IJMS | Free Full-Text | Second Cancer Onset in Myeloproliferative  Neoplasms: What, When, Why?
IJMS | Free Full-Text | Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?

PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome:  Consensus of an Italian expert panel | R. Masetti - Academia.edu
PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu

Type of the Paper (Article
Type of the Paper (Article

Prof.ssa Giorgina Specchia, ematologo - Prenota online | MioDottore.it
Prof.ssa Giorgina Specchia, ematologo - Prenota online | MioDottore.it

Prof.ssa Giorgina Specchia: ematologa a Bari
Prof.ssa Giorgina Specchia: ematologa a Bari

V.LE LUIGI EINAUDI, 11/0 – 70125 339 1684398 specchiagiorgina@gmail.com  SPCGGN49L71I950A
V.LE LUIGI EINAUDI, 11/0 – 70125 339 1684398 specchiagiorgina@gmail.com SPCGGN49L71I950A

FORMATO EUROPEO PER IL CURRICULUM VITAE
FORMATO EUROPEO PER IL CURRICULUM VITAE

G. Specchia - Emocromo (Relazione) on Vimeo
G. Specchia - Emocromo (Relazione) on Vimeo

Core Curriculum - Ematologia - LibriScientifici.com
Core Curriculum - Ematologia - LibriScientifici.com